CD109 and head and neck squamous cell carcinoma: Furthermore, we corroborated our findings above with a larger number (n = 109) of patients by proteomic analysis of data on HPV negative HNSCC patients from the LinkedOmics database and dividing them into CD109 high versus CD109 low groups (see Methods).